- Raised $42M funding round led by Fortissimo Capital, Jul 2024
- Raised $50M funding round, Feb 2022
- Raised $10M funding round led by Viola Growth, Jul 2025
About
Scopio Labs has designed and built a computational microscope and developed a proprietary diagnostics platform to enable quality microscopic analysis, with the aim of providing easy and wide access to microscopy. By merging hardware and software, the companys ultimate goal is to provide better diagnostics for everyone.
Scopio Labs smart digitized system bolsters manual examination by automating the majority of the screening process. It automatically scans the relevant area of the slide, preclassifies cells, and prepares the information for quick review in order to increase efficiency and connectivity while reducing the effects of human error. The digital microscopy solution is designed to improve overall usability, produce a platform accessible to all labs, and increase accuracy and connectivity by capturing the entire sample as opposed to individual cells.
The Full-Field Peripheral Blood Smear Application on the X100 is the first end-to-end digital solution that offers full-field imaging and an AI-powered Decision Support System (DSS) with remote connectivity through your secure hospital network. The Full-Field Peripheral Blood Smear Application (FF-PBS) on the X100 is FDA Cleared and CE Marked.
Funding history · 9 rounds · $126.8M total
Q&A
- What is Scopio Labs' primary business?
- Scopio Labs specializes in computational microscopy for blood diagnostics, developing a proprietary diagnostics platform and computational microscope to enable quality microscopic analysis.
- When was Scopio Labs founded?
- Scopio Labs was founded in October 2014.
- How many employees does Scopio Labs currently have?
- Scopio Labs has 51–200 employees.
- What is the total funding raised by Scopio Labs to date?
- Scopio Labs has raised a total of $126,757,700 USD.
- When was Scopio Labs' most recent funding round and who were the lead investors?
- In July 2025, Scopio Labs raised $10,000,000 with.
- Which investors participated in Scopio Labs' July 2024 funding round?
- In July 2024, Scopio Labs raised $42,000,000 with.
- What is Scopio Labs' current funding stage?
- Scopio Labs is currently in its Series D funding stage.
- What is a key product offering from Scopio Labs?
- Scopio Labs offers the Full-Field Peripheral Blood Smear Application on the X100, an end-to-end digital solution with full-field imaging and an AI-powered Decision Support System (DSS), which is FDA Cleared and CE Marked.
- Who are the co-founders of Scopio Labs?
- The co-founders of Scopio Labs are Itai Hayut, who serves as CEO, and Erez Na'aman, who serves as CTO.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | scopiolabs.com |
|---|---|
| linkedin.com/company/10048158 | |
| facebook.com/scopiolabs | |
| YouTube | youtube.com/channel/UCYTn70Vh7jK9fnSbYrsjg7A |
| Wikidata | wikidata.org/wiki/Q137825984 |
Identifiers & details
| Founded | 2014-10 |
|---|---|
| Employees (exact) | 156 |
| Offices | United States |
| Wikidata QID | Q137825984 |
Radar intelligence
Patents
| EPO | 20 |
|---|
GitHub
| Top repos | logstash_logger, PIXIL, AttributeHighlighter |
|---|
Web history (Wayback)
| Domain | scopiolabs.com |
|---|
Wikidata
| QID | Q137825984 |
|---|
Certificate / subdomain footprint
| Subdomains | 85 |
|---|